If you received Depo-Provera birth control shots and developed a brain tumor, find out if settlement benefits may be available.
Our product liability attorneys are investigating Depo-Provera lawsuits against Pfizer Inc. for failing to warn about the risk of serious side effects:
Find out if you or a loved one qualify for a Depo-Provera lawsuit payout. Contact us on-line to schedule a case review or call our product liability attorneys anytime at (612) 981-9232 for a free consultation.
There are no fees or expenses unless a settlement or recovery is obtained.
Our lawyers are investigating Depo-Provera lawsuits for women throughout the United States after new evidence has linked the birth control shots to an increased risk of brain tumors known as meningioma.
Depo-Provera is a hormonal birth control injection that contains medroxyprogesterone acetate, a synthetic form of the hormone progesterone. It was approved by the U.S. Food and Drug Administration (FDA) in 1992 and is advertised to prevent pregnancy by inhibiting ovulation, thickening cervical mucus to block sperm, and thinning the uterine lining to prevent a fertilized egg from implanting.
As of October 22, 2024, growing concerns have emerged regarding the contraceptive injection Depo-Provera, particularly due to inconsistencies in safety warnings between the United States and Europe. While European labels caution about a possible link between Depo-Provera and meningiomas—tumors affecting the protective membranes of the brain—the U.S. version lacks this warning. This raises serious concerns about patient safety, transparency, and regulatory oversight.
Depo-Provera has been widely used for contraception, but recent findings suggest a potential association between long-term use and meningioma development. Many women who have received Depo-Provera injections and later experienced severe health issues are now questioning the safety of this medication.
If you believe you have suffered adverse effects from Depo-Provera, you are not alone. InjuryClaim Center is here to connect you with trusted legal professionals who can help you fight for your rights and seek the compensation you may deserve.
| Type of Meningioma | Description |
|---|---|
| Benign Meningiomas | The most common type, slow-growing and non-cancerous. |
| Atypical Meningiomas | Grow more aggressively and have a higher chance of recurrence. |
| Malignant Meningiomas | Cancerous, though rare, and can spread to surrounding tissues. |
Women who have been diagnosed with meningiomas after using Depo-Provera are now taking legal action against the manufacturer, claiming they were not adequately warned about the risks. These lawsuits aim to hold the company accountable while helping victims recover compensation for:
If you or a loved one has suffered health complications due to Depo-Provera, you may be eligible for legal action. InjuryClaim Center can connect you with experienced legal experts who will guide you through the process and help you fight for the compensation you deserve.
Contact us today to learn more about your legal options and take the first step toward justice.
On February 7, 2025, the U.S. Judicial Panel on Multidistrict Litigation (JPML) issued a transfer order consolidating all Depo-Provera meningioma lawsuits in the Northern District of Florida as part of MDL No. 3140.
The defendants listed in the Depo-Provera lawsuits include:
Depo-Provera is a contraceptive injection that delivers medroxyprogesterone acetate, a synthetic version of the hormone progestin...
There are absolutely no out-of-pocket costs to review your case or hire our Depo-Provera attorneys.
Depo-Provera lawsuits are evaluated for individuals throughout the United States, and all cases are handled on a contingency fee basis.
Through the use of contingency attorney fees, individuals have access to the experience and resources of our national law firm for their potential Depo-Provera lawsuit — regardless of their individual financial resources.
